Personalised medicine: the next leap forward for health care?
As health care becomes more competitive, companies are securing an advantage through personalised medicine development.
Joanna is a global healthcare analyst in the 4Factor team at Ninety One.
Prior to joining the firm in 2017, she worked at Valiance as a healthcare analyst. Before that, Joanna worked at Goldman Sachs as a pharmaceutical and biotechnology equity research analyst.
Joanna holds a Bachelor’s degree in Biochemistry from University College London and a PhD in Medical Sciences from Queens’ College Cambridge.